JP2023546300A5 - - Google Patents
Info
- Publication number
- JP2023546300A5 JP2023546300A5 JP2023548545A JP2023548545A JP2023546300A5 JP 2023546300 A5 JP2023546300 A5 JP 2023546300A5 JP 2023548545 A JP2023548545 A JP 2023548545A JP 2023548545 A JP2023548545 A JP 2023548545A JP 2023546300 A5 JP2023546300 A5 JP 2023546300A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2016659.1 | 2020-10-20 | ||
| GBGB2016659.1A GB202016659D0 (en) | 2020-10-20 | 2020-10-20 | Methods and compositions for cellular therapy |
| GBGB2101665.4A GB202101665D0 (en) | 2021-02-05 | 2021-02-05 | Methods and compositions for cellular therapy |
| GB2101665.4 | 2021-02-05 | ||
| PCT/US2021/055682 WO2022087019A1 (en) | 2020-10-20 | 2021-10-19 | Methods and compositions for cellular therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023546300A JP2023546300A (ja) | 2023-11-01 |
| JP2023546300A5 true JP2023546300A5 (https=) | 2024-10-25 |
| JPWO2022087019A5 JPWO2022087019A5 (https=) | 2024-10-25 |
Family
ID=81290046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548545A Pending JP2023546300A (ja) | 2020-10-20 | 2021-10-19 | 細胞治療のための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240124551A1 (https=) |
| EP (1) | EP4232468A4 (https=) |
| JP (1) | JP2023546300A (https=) |
| KR (1) | KR20230110258A (https=) |
| AU (1) | AU2021364550A1 (https=) |
| CA (1) | CA3196346A1 (https=) |
| GB (1) | GB2619410A (https=) |
| WO (1) | WO2022087019A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102776627B1 (ko) | 2019-05-06 | 2025-03-06 | 토마스 말콤 | 암 종양에 대한 맞춤화된 하이포면역 나노소포체 전달 시스템 |
| GB202205771D0 (en) * | 2022-04-20 | 2022-06-01 | Replay Holdings Llc | Methods and compositions for cellular therapy |
| GB202316281D0 (en) * | 2023-10-24 | 2023-12-06 | Replay Holdings Inc | Methods and compositions for modulating immune cell activity in cellular therapy |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10503379A (ja) * | 1994-07-29 | 1998-03-31 | デイド・インターナショナル・インコーポレーテッド | Ｍｈｃ複合体およびその用途 |
| US6211342B1 (en) * | 1996-07-18 | 2001-04-03 | Children's Hospital Medical Center | Multivalent MHC complex peptide fusion protein complex for stimulating specific T cell function |
| GB0107628D0 (en) * | 2001-03-27 | 2001-05-16 | Avidex Ltd | Substances |
| GB0115071D0 (en) * | 2001-06-20 | 2001-08-15 | Avidex Ltd | Substances |
| US8895020B2 (en) * | 2002-04-19 | 2014-11-25 | Washington University | Single chain trimers and uses therefor |
| US9765330B1 (en) * | 2015-01-09 | 2017-09-19 | Nant Holdings Ip, Llc | Compositions and methods for reduction of allograft recognition and rejection |
| WO2018089661A1 (en) * | 2016-11-09 | 2018-05-17 | La Jolla Institute For Allergy And Immunology | Use of c-terminally extended peptides to disrupt inhibitor nk cell receptor interactions with mhc i |
| CN110177869A (zh) * | 2017-01-13 | 2019-08-27 | 加利福尼亚大学董事会 | 免疫改造的多能细胞 |
| RU2764620C2 (ru) * | 2018-07-10 | 2022-01-18 | Общество С Ограниченной Ответственностью "Бетарут" | Способ и устройство жидкой ковки двойного действия |
| US12331318B2 (en) * | 2018-07-13 | 2025-06-17 | Lothar Germeroth | Non-immunogenic engineered tissue and methods of producing and using the same |
| WO2020051373A1 (en) * | 2018-09-06 | 2020-03-12 | Optumsoft, Inc. | Automatic generation of an efficient rule set implementation |
-
2021
- 2021-10-19 EP EP21883739.1A patent/EP4232468A4/en active Pending
- 2021-10-19 CA CA3196346A patent/CA3196346A1/en active Pending
- 2021-10-19 GB GB2306292.0A patent/GB2619410A/en active Pending
- 2021-10-19 JP JP2023548545A patent/JP2023546300A/ja active Pending
- 2021-10-19 KR KR1020237016408A patent/KR20230110258A/ko not_active Withdrawn
- 2021-10-19 WO PCT/US2021/055682 patent/WO2022087019A1/en not_active Ceased
- 2021-10-19 AU AU2021364550A patent/AU2021364550A1/en not_active Abandoned
-
2023
- 2023-04-19 US US18/303,075 patent/US20240124551A1/en active Pending